Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Macrophage migration inhibitory factor (MIF) is an important pro-inflammatory cytokine expressed at sites of inflammation. We have assessed this factor (MIF) in urinary tract infections with the aim of determining a non-invasive and sensitive method to differentiate upper and lower renal involvement. Thirty-three pediatric patients with urinary track infection (25 with acute pyelonephritis, eight with acute cystitis) and 40 healthy subjects were recruited for this prospective case-control study. Pyelonephritis was differentiated from cystitis by dimercaptosuccinic acid (DMSA) scan. Urinary MIF concentration was determined using an enzyme-linked immunosorbent assay method. The urine MIF/creatinine (Cr) ratio was significantly higher in pyelonephritis patients than in those with acute cystitis and the control group (P < 0.001). The optimal cut-point of 4.90 pg/micromol Cr for the urine MIF/Cr ratio has the potential to be a biomarker for distinguishing patients with acute pyelonephritis from those with acute cystitis. Determination of the urinary MIF was also useful in selecting the patients at risk of permanent renal damage. Of those patients with pyelonephritis, based on the DMSA scan at the time of infection, scarring on follow-up DMSA scan 9-12 months later occurred in patients with the highest urinary MIF/Cr ratios. We conclude that the urine MIF/Cr ratio is a sensitive test for differentiating acute pyelonephritis from acute cystitis and also for detecting children with acute pyelonephritis who are at a higher risk for permanent renal scars in the future.
Otukesh
Hasan
H
Urology and Nephrology Research Center, Labbafi Nejad Hospital, Tehran, Iran.
Fereshtehnejad
Seyed-Mohammad
SM
Hoseini
Rozita
R
Hekmat
Sepideh
S
Chalian
Hamid
H
Chalian
Majid
M
Bedayat
Arash
A
Salman Yazdi
Reza
R
Sabaghi
Saeed
S
Mahdavi
Saeed
S
D000208:Acute Disease; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D002921:Cicatrix / Q000175:diagnosis / Q000209:etiology / Q000652:urine; D003556:Cystitis / Q000175:diagnosis* / Q000652:urine; D005260:Female; D006801:Humans; D008263:Macrophage Migration-Inhibitory Factors / Q000652:urine*; D008297:Male; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011704:Pyelonephritis / Q000150:complications / Q000175:diagnosis* / Q000652:urine; D012372:ROC Curve; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D016482:Urinalysis; D014552:Urinary Tract Infections / Q000150:complications / Q000175:diagnosis* / Q000652:urine
D008263:Macrophage Migration-Inhibitory Factors; D019783:Technetium Tc 99m Dimercaptosuccinic Acid
Gastroenterology. 2002 Jul;123(1):256-70
12105854
J Exp Med. 1994 Jun 1;179(6):1895-902
8195715
Pediatr Nephrol. 1995 Apr;9(2):131-6
7794702
Mol Med. 1998 Apr;4(4):217-30
9606175
Arch Dis Child. 1992 Nov;67(11):1338-42
1335226
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7849-54
8755565
Am J Pathol. 1997 Jan;150(1):235-46
9006339
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4782-7
9114069
Adv Immunol. 1997;66:197-223
9328642
J Interferon Cytokine Res. 2004 Jan;24(1):55-63
14980085
J Am Soc Nephrol. 1998 Mar;9(3):417-24
9513903
Mol Med. 1995 Nov;1(7):781-8
8612200
J Urol. 2005 Jul;174(1):338-43
15947686
Clin Exp Immunol. 2003 Feb;131(2):225-33
12562381
J Urol. 2003 Aug;170(2 Pt 1):623-7
12853844
J Clin Invest. 1998 Jun 15;101(12):2869-74
9637721
Pediatr Nephrol. 1997 Feb;11(1):108-20
9035184
Mol Med. 1997 Feb;3(2):136-44
9085256
J Urol. 2006 Apr;175(4):1523-8
16516040
Endocrinology. 1996 Nov;137(11):5090-5
8895383
J Nucl Med. 2000 Jun;41(6):986-93
10855622
Arthritis Rheum. 2003 Feb;48(2):291-9
12571836
Clin Exp Immunol. 1997 May;108(2):318-23
9158105
BMC Neurosci. 2003 Aug 08;4:17
12908877
J Pediatr. 1994 Jan;124(1):17-20
8283371
Gastroenterology. 2001 Sep;121(3):619-30
11522746
Br J Dermatol. 1999 Dec;141(6):1061-6
10606853
Pediatrics. 1999 Jul;104(1 Pt 1):79-86
10390264
Pediatr Nephrol. 2005 Oct;20(10 ):1439-44
16082551